Weighted Average Number of Shares Outstanding, Basic of Co-Diagnostics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Co-Diagnostics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 37,890,923, a 24% increase year-over-year.
  • Co-Diagnostics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 30,335,350, a 3.4% increase from 2023.
  • Co-Diagnostics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 29,346,599, a 6.8% decline from 2022.
  • Co-Diagnostics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 31,479,028, a 9% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 37,890,923 +7,396,717 +24% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 33,108,399 +2,983,703 +9.9% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 32,048,953 +2,206,079 +7.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 30,335,350 +988,751 +3.4% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 30,494,206 +1,132,906 +3.9% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 30,124,696 +1,036,537 +3.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 29,842,874 +359,334 +1.2% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 29,346,599 -2,132,429 -6.8% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 29,361,300 -1,960,068 -6.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 29,088,159 -3,384,092 -10% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 29,483,540 -4,452,030 -13% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 31,479,028 +2,604,473 +9% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 31,321,368 +2,380,011 +8.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 32,472,251 +3,678,204 +13% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 33,935,570 +5,272,685 +18% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 28,874,555 +2,154,422 +8.1% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 28,941,357 +857,090 +3.1% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 28,794,047 +1,211,818 +4.4% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 28,662,885 +5,842,435 +26% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 26,720,133 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 28,084,267 +10,755,480 +62% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 27,582,229 +10,564,265 +62% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 22,820,450 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 17,328,787 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 17,017,964 01 Apr 2019 30 Jun 2019 10-Q/A 03 Nov 2020 2020 Q2

Co-Diagnostics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 30,335,350 +988,751 +3.4% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 29,346,599 -2,132,429 -6.8% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 31,479,028 +2,604,473 +9% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 28,874,555 +2,154,422 +8.1% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 26,720,133 +9,963,221 +59% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 16,756,912 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.